A new biotech startup developing breakthrough vision treatments has sparked investor interest. The company, whose CEO has a ton of expertise in the field, has already inked drug licensing deals and ...

Behind the scenes, major pharmaceutical companies and Trump-tied billionaires are furiously lobbying in opposite directions ...

Shareholders continued to sell down CSL despite its investment in a blood disorder biotech, saying they want more signs of ...

Popular investor Cathie Wood’s ARK Invest made key portfolio moves on Monday, September 15, 2025, with the spotlight on a ...

AI is making waves in biotechnology. Advanced AI systems, known as foundation models, can suggest new protein designs, fine-tune metabolic processes, and even guide people with limited lab experience ...

Discover the top biotech deals of August 2025, as several big pharmas shopped around, especially in the field of small ...

Since the material prolongs the shelf life of fruits and vegetables, customers can save money on groceries while enjoying ...

A $30M workforce initiative – anchored by a job-training facility with mock cleanrooms and labs – would help Central Ohioans gain high-paying jobs while attracting more biotech companies to the region ...

A new report from the Massachusetts Biotechnology Council, or MassBio, identified an ongoing slump in the state’s life ...

A deal with Dutch startup VarmX gives CSL an option to buy a Phase 3-ready drug that could reverse the effects of popular ...

Here is our list of the 11 best-performing biotech stocks so far in 2025.

For biotech firms, a bit of positive news—a key result from clinical trials or new drug discovery, say—can be the difference between a major rally based on a path toward sustained profitability and a ...